Efficient Presentation of Multiple Endogenous Epitopes to Both CD4(+) and CD8(+) Diabetogenic T Cells for Tolerance

Antigen-specific immunotherapy of type 1 diabetes, typically via delivery of a single native β cell antigen, has had little clinical benefit to date. With increasing evidence that diabetogenic T cells react against multiple β cell antigens, including previously unappreciated neo-antigens that can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Dastagir, Shamael R., Postigo-Fernandez, Jorge, Xu, Chunliang, Stoeckle, James H., Firdessa-Fite, Rebuma, Creusot, Rémi J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363322/
https://www.ncbi.nlm.nih.gov/pubmed/28344989
http://dx.doi.org/10.1016/j.omtm.2016.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363322/
https://www.ncbi.nlm.nih.gov/pubmed/28344989
http://dx.doi.org/10.1016/j.omtm.2016.12.002

Ejemplares similares